Fox Business - The Power to Prosper
Search Site

William Ackman

Herbalife CFO: We will not run away from Ackman ’s accusations

Herbalife CFO John DeSimone reacts to Pershing Square Capital Management CEO Bill Ackman ’s latest attacks.

Read More

  1. Stock Futures Steady Amid Raft of Health M&A

    FOX Business: Capitalism Lives HereU.S. stock-index futures were little changed on Tuesday as traders eyed a slew of merger activity in the pharmaceutical sector. To...

  2. M&A Buzz Boosts Markets

    FOX Business: Capitalism Lives HereA jolt of deal-making in the biotechnology sector, combined with generally upbeat earnings news, sent Wall Street climbing higher....

  3. Wall Street Ticks Up as Traders Parse News Deluge

    FOX Business: Capitalism Lives HereU.S. stocks inched higher on Tuesday as traders reviewed a flood of corporate earnings and deal news.Today's MarketsAs of 9:32 a.m...

  4. Allergan Rallies On Report Of Valeant, Ackman Bid

    Shares of Allergan Inc. and Valeant Pharmaceuticals Inc. made double-digit percentage gains after hours Monday ona report from the Wall Street Journal that Valeant a...

  5. Pershing , Valeant Team Up in Bid to Buy Allergan

    Hedge fund manager Bill Ackman is joining forces with Valeant Pharmaceutical (NYSE:VRX) in a bid to snatch up Allergan (NYSE:AGN), the maker of Botox. Ackman, who he...

  6. Pershing Chief Contributed to Schneiderman AG Campaign

    New York State Attorney General Eric Schneiderman launched a probe into whether nutritional-supplement maker Herbalife (NYSE:HLF) is an illegal pyramid scheme after ...

  7. Herbalife Builds Website to Counter Fraud Claims

    Weight loss and nutrition company Herbalife (NYSE:HLF) launched a website on Tuesday that details its business practices and counters claims made by billionaire inve...

  8. Carl Icahn on Herbalife

    Billionaire investor Carl Icahn on rival Bill Ackman and nutrition company Herbalife.

  9. Activist battle: Loeb vs Ackman

    FBN’s Charlie Gasparino breaks down the feud between investors Daniel Loeb and Bill Ackman .

  10. Loeb's Worst Stock Pick Ever Came Courtesy of Bill Ackman

    The worst investment shareholder activist Daniel Loeb ever made was the result of a bad tip from a former friend, fellow activist Bill Ackman. In fact, the investmen...

  11. Activists' Next Target: GE?

    Could General Electric (NYSE:GE) be the next target of activist investors?Some people inside the mega company think so, which is one reason they say chief executive ...

  12. Investors Back Fannie, Freddie Despite Lawmaker Plans

    A Senate proposal for winding down Fannie Mae and Freddie Mac slammed their shares over the last two days, but big investors in the government-owned mortgage agencie...

  1. Ackman compares Herbalife to Enron

    Maureen Farrell of The Wall Street Journal on Pershing Square Capital Management CEO Bill Ackman ’s comments on Herbalife.

  2. The paths to profits in Ackman ’s Herbalife war

    FBN contributor Bob Rice delves into Pershing Square Capital Management CEO Bill Ackman ’s disclosure of details into Herbalife’s investigation.

  3. Allergan: Back off, Ackman

    Wall Street Journal reporter David Benoit and FOX Business contributor Bob Rice on Allergan looking to potential acquisitions to fend off activist investor Bill Ackman .

  4. Ackman : No Laws Broken in Allergan Buy

    Billionaire activist investor William Ackman said today that the way he accumulated his stake in Botox-maker Allergan (NYSE:AGN) was above the board and did not viol...

  5. ValueAct's Ubben says firm will not seek new term on Valeant board

    Hedge fund manager Jeffrey Ubben, whose firm ValueAct sits on the board of Valeant Pharmaceuticals, said on Tuesday that the hedge fund will not seek reelection on t...

  6. Allergan, Valeant Shares Rally On Buyout Offer

    In an unusual partnership with activist investor William Ackman, Valeant Pharmaceuticals International Inc. proposed to buy Botox-maker Allergan Inc. on Tuesday. Und...

  7. Valeant Submits Merger Proposal to Allergan Board

    Valeant Pharmaceuticals (NYSE:VRX) on Tuesday unveiled a cash-and-stock buyout offer for Botox-maker Allergan (NYSE:AGN). The deal, which was initially announced Mon...

‹ Prev12345Next ›
Freebase CC-BY
Source: William Ackman on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL